Stay updated on Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.

Latest updates to the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page
- Check5 days agoChange DetectedThe record's revision tag was updated to v3.7.0, indicating a new version of the page template; the prior revision metadata (v3.6.6) has been superseded.SummaryDifference17%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision indicator was updated from v3.6.5 to v3.6.6, reflecting a minor update to the page's metadata. No study content or visible functionality is altered.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page shows a revision from v3.6.4 to v3.6.5, representing an update to the site's underlying software. This appears to be a maintenance release that does not modify the study data or user-facing content.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision label v3.6.4 is added, indicating a small deployment update to the page. No substantive study details or user-facing content changes are evident.SummaryDifference0.1%

- Check83 days agoChange DetectedThe revision indicator on the page has updated from v3.6.2 to v3.6.3, signaling a newer version of the page. This update reflects a version refresh rather than changes to the study information itself.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page footer revision label changed from v3.6.0 to v3.6.2, indicating a newer page version or update to the underlying template.SummaryDifference0.1%

Stay in the know with updates to Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.